PL1729775T3 - Sposób i związki pośrednie do wytwarzania statyn, zwłaszcza resuwastatyny - Google Patents
Sposób i związki pośrednie do wytwarzania statyn, zwłaszcza resuwastatynyInfo
- Publication number
- PL1729775T3 PL1729775T3 PL05731809T PL05731809T PL1729775T3 PL 1729775 T3 PL1729775 T3 PL 1729775T3 PL 05731809 T PL05731809 T PL 05731809T PL 05731809 T PL05731809 T PL 05731809T PL 1729775 T3 PL1729775 T3 PL 1729775T3
- Authority
- PL
- Poland
- Prior art keywords
- formula
- compound
- group
- protecting
- protecting group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0406757A GB0406757D0 (en) | 2004-03-26 | 2004-03-26 | Process and compounds |
| PCT/GB2005/001099 WO2005092867A2 (en) | 2004-03-26 | 2005-03-23 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
| EP20050731809 EP1729775B1 (en) | 2004-03-26 | 2005-03-23 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1729775T3 true PL1729775T3 (pl) | 2011-03-31 |
Family
ID=32188702
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05731809T PL1729775T3 (pl) | 2004-03-26 | 2005-03-23 | Sposób i związki pośrednie do wytwarzania statyn, zwłaszcza resuwastatyny |
| PL08157487T PL1958633T3 (pl) | 2004-03-26 | 2005-03-23 | Proces i związki pośrednie użyteczne do przygotowania statyn, w szczególności rosuwastatyny |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08157487T PL1958633T3 (pl) | 2004-03-26 | 2005-03-23 | Proces i związki pośrednie użyteczne do przygotowania statyn, w szczególności rosuwastatyny |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8703945B2 (pl) |
| EP (2) | EP1958633B1 (pl) |
| JP (1) | JP5016478B2 (pl) |
| KR (1) | KR20060130765A (pl) |
| CN (1) | CN101022807B (pl) |
| AT (2) | ATE536875T1 (pl) |
| AU (1) | AU2005225602A1 (pl) |
| BR (1) | BRPI0507999A (pl) |
| CA (1) | CA2561059C (pl) |
| CY (2) | CY1110091T1 (pl) |
| DE (1) | DE602005019547D1 (pl) |
| DK (2) | DK1729775T3 (pl) |
| ES (2) | ES2379481T3 (pl) |
| GB (1) | GB0406757D0 (pl) |
| HR (1) | HRP20100287T1 (pl) |
| IL (1) | IL178274A0 (pl) |
| PL (2) | PL1729775T3 (pl) |
| PT (2) | PT1729775E (pl) |
| RS (1) | RS51306B (pl) |
| SI (2) | SI1958633T1 (pl) |
| WO (1) | WO2005092867A2 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003006439A1 (en) | 2001-07-13 | 2003-01-23 | Astrazeneca Uk Limited | Preparation of aminopyrimidine compounds |
| GB0218781D0 (en) | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
| GB0312896D0 (en) | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
| GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
| GB0406757D0 (en) * | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
| GB0427491D0 (en) | 2004-12-16 | 2005-01-19 | Avecia Ltd | Process and compounds |
| US9150518B2 (en) | 2005-06-24 | 2015-10-06 | Lek Pharmaceuticals, D.D. | Process for preparing amorphous rosuvastatin calcium of impurities |
| US8183397B2 (en) | 2007-04-03 | 2012-05-22 | Lek Pharmaceuticals D.D. | Synthesis of statins |
| EP1978020A1 (en) * | 2007-04-03 | 2008-10-08 | LEK Pharmaceuticals D.D. | Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof |
| CN101952453B (zh) | 2008-01-23 | 2015-02-25 | 力奇制药公司 | ((2s,4r)-4,6-二羟基四氢-2h-吡喃-2-基)甲基羧酸酯及使用2-脱氧核糖-5-磷酸醛缩酶的制备方法 |
| GB0904104D0 (en) | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Atorvastatin and rosuvastatin derivatives |
| AU2013202895B2 (en) * | 2009-03-10 | 2014-09-18 | Redx Pharma Plc | Rosuvastatin and atorvastatin derivatives |
| GB0904100D0 (en) | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Use of rosuvastatin lactols as medicaments |
| GB0904102D0 (en) * | 2009-03-10 | 2009-04-22 | Bradford Pharma Ltd | Use of atorvastatin lactols as medicaments |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474971A (en) * | 1982-09-29 | 1984-10-02 | Sandoz, Inc. | (Tetrahydropyran-2-yl)-aldehydes |
| US4625039A (en) * | 1983-12-21 | 1986-11-25 | Sandoz Pharm. Corp. | 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates |
| US4677211A (en) | 1984-06-29 | 1987-06-30 | Sandoz Pharmaceuticals Corp. | Preparation of lactones |
| JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US5795749A (en) | 1995-04-05 | 1998-08-18 | The Scripps Research Institution | Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives |
| GB9903472D0 (en) | 1999-02-17 | 1999-04-07 | Zeneca Ltd | Chemical process |
| WO2001022962A1 (en) * | 1999-09-30 | 2001-04-05 | Merck & Co., Inc. | Anti-hypercholesterolemic drug combination |
| GB0003305D0 (en) * | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
| GB0011163D0 (en) * | 2000-05-10 | 2000-06-28 | Astrazeneca Ab | Chemical compound |
| EP1465667A4 (en) * | 2001-09-24 | 2007-06-27 | Merck & Co Inc | SCREENING AND SELECTION PROCEDURE FOR STATIN COMBINATIONS |
| DE10216967A1 (de) * | 2002-04-16 | 2003-11-13 | Bayer Ag | Verfahren zur Herstellung spezieller aromatischer Aldehyde |
| US7371759B2 (en) | 2003-09-25 | 2008-05-13 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| WO2005040134A1 (en) * | 2003-10-22 | 2005-05-06 | Ranbaxy Laboratories Limited | Process for the preparation of amorphous rosuvastatin calcium |
| DE10352659B4 (de) | 2003-11-11 | 2007-09-13 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren |
| GB0406757D0 (en) * | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
-
2004
- 2004-03-26 GB GB0406757A patent/GB0406757D0/en not_active Ceased
-
2005
- 2005-03-23 ES ES08157487T patent/ES2379481T3/es active Active
- 2005-03-23 SI SI200531491T patent/SI1958633T1/sl unknown
- 2005-03-23 EP EP20080157487 patent/EP1958633B1/en not_active Not-in-force
- 2005-03-23 AU AU2005225602A patent/AU2005225602A1/en not_active Abandoned
- 2005-03-23 EP EP20050731809 patent/EP1729775B1/en active Active
- 2005-03-23 DK DK05731809T patent/DK1729775T3/da active
- 2005-03-23 PT PT05731809T patent/PT1729775E/pt unknown
- 2005-03-23 PL PL05731809T patent/PL1729775T3/pl unknown
- 2005-03-23 CN CN2005800096821A patent/CN101022807B/zh not_active Expired - Fee Related
- 2005-03-23 ES ES05731809T patent/ES2341658T3/es active Active
- 2005-03-23 DK DK08157487T patent/DK1958633T3/da active
- 2005-03-23 RS RSP20100217 patent/RS51306B/sr unknown
- 2005-03-23 PL PL08157487T patent/PL1958633T3/pl unknown
- 2005-03-23 CA CA 2561059 patent/CA2561059C/en not_active Expired - Fee Related
- 2005-03-23 DE DE200560019547 patent/DE602005019547D1/de active Active
- 2005-03-23 BR BRPI0507999-3A patent/BRPI0507999A/pt not_active Application Discontinuation
- 2005-03-23 US US10/594,380 patent/US8703945B2/en not_active Expired - Fee Related
- 2005-03-23 KR KR20067021900A patent/KR20060130765A/ko not_active Application Discontinuation
- 2005-03-23 AT AT08157487T patent/ATE536875T1/de active
- 2005-03-23 PT PT08157487T patent/PT1958633E/pt unknown
- 2005-03-23 AT AT05731809T patent/ATE458484T1/de active
- 2005-03-23 WO PCT/GB2005/001099 patent/WO2005092867A2/en active Application Filing
- 2005-03-23 JP JP2007504474A patent/JP5016478B2/ja not_active Expired - Fee Related
- 2005-03-23 SI SI200531001T patent/SI1729775T1/sl unknown
-
2006
- 2006-09-25 IL IL178274A patent/IL178274A0/en unknown
-
2010
- 2010-05-21 HR HR20100287T patent/HRP20100287T1/hr unknown
- 2010-05-21 CY CY101100456T patent/CY1110091T1/el unknown
-
2012
- 2012-03-14 CY CY20121100274T patent/CY1115040T1/el unknown
-
2014
- 2014-03-25 US US14/225,018 patent/US9024025B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL178274A0 (en) | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin | |
| GB0719180D0 (en) | New process | |
| EP2072582A4 (en) | POLYMERIC COMPOSITION WITH METAL ALKOXIDE CONDENSATION PRODUCT, ORGANIC SILANE COMPOUND AND BORON COMPOUND | |
| SG165361A1 (en) | Antituberculous composition comprising oxazole compounds | |
| ATE497948T1 (de) | Bicyclische verbindungen | |
| ATE328858T1 (de) | Verfahren zur alkoxylierung mit einem bor- enthaltenden katalysator | |
| EP1555261A4 (en) | VALEROLACTONE COMPOUNDS AND FRAGRANCE COMPOSITION | |
| HK1088604A1 (en) | Process for the production of 1-acetoxy-3- (substituted phenyl) propenes | |
| WO2008078041A3 (fr) | Procede de preparation de composes 1,3,2-oxazaborolidines | |
| TW200704632A (en) | Process for the preparation of 1-[cyano(4-hydroxyphenyl)methyl]cyclohexanol compounds | |
| IL185884A0 (en) | Method for preparing substittuted pyrimidines | |
| CA2530163A1 (en) | Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin | |
| DK1598358T3 (da) | Forbindelser indeholdende 3,4-methylendioxythiophen-enheder | |
| IL108829A0 (en) | Enzymatic resolution of alkyl 2-piperidinecarboxylates and use of the compounds obtained as synthesis intermediates | |
| MY152869A (en) | Chemical process | |
| TW200720282A (en) | Novel organosilicon compound and process for producing the same | |
| WO2002002098A3 (en) | Antibacterial method and composition with phenolic compounds | |
| ATE293095T1 (de) | Verfahren zur herstellung von cyclopropancarboxylaten | |
| ES2157679T3 (es) | Procedimiento para preparar un compuesto de 2-cianobifenilo. | |
| EP1726645A4 (en) | PROCESS FOR PREPARING PICOLIC ACID COMPOUNDS | |
| AU2003231926A1 (en) | NOVEL PROCESS FOR STEREOSELECTIVE REDUCTION OF ss-KETOESTERS | |
| EP1930331A4 (en) | PROCESS FOR PRODUCING IMIDAZO [1,2-b] PYRIDAZINE COMPOUND | |
| TW200712054A (en) | Method for producing 2,3-dihydropyridazine compound | |
| ATE366719T1 (de) | Verfahren zur herstellung von 2,6- dichlorphenolverbindungen | |
| TH52585B (th) | อนุพันธ์ไอโซไธอะโซล |